Renal cell carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects volunteered to participate in the study, provided signed and dated written informed consent prior to any study-specific procedures, sampling, and analysis, had good compliance, and cooperated with follow-up; 2. Age >=30 years and =2*10^9/L; 3) HB 90 g/L or higher; 4) The ANC acuity 1.5*10^9/L; 5) PLT acuity 100*10^9/L; (2) Without functional organic disease, the following criteria must be met: 1) T-bil 30ml/min (cockcroft-gault formula); 5) International normalized ratio (INR), activated partial thromboplastin time (aPTT): =60mL/min according to cockcroft-gault formula.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of malignant tumors other than renal cell carcinoma; 2. Patients with postoperative pathological non-renal cell carcinoma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metabolic phenotype; | — |
Countries
China
Contacts
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine